Business News
Intel stock falls on rating downgrade after dismal profit guidance
Shares of Intel (Nasdaq: INTC) opened sharply lower Thursday and remained low during the session, reflecting investors' concern over the…
Earnings: Roku Q1 results beat on solid user growth; stock surges
Roku Inc. (NASDAQ: ROKU) on Wednesday reported a narrower than expected net loss for the March quarter, triggering a stock…
Fiber network operator Zayo to be taken private in $14-billion deal
Network infrastructure provider Zayo Group Holdings (NYSE: ZAYO) Wednesday said it has agreed to be taken private. The company entered into…
Earnings: Plug Power Q1 loss widens on lower revenues; stock falls
Plug Power (Nasdaq: PLUG) reported a wider net loss for the first quarter of 2019, owing to a 30% fall…
Electronic Arts Q4 earnings miss estimates; stock gains on positive guidance
Underscoring the general weakness in its business, Electronic Arts (Nasdaq: EA) reported a sharp decline in fourth-quarter revenues and profit.…
GM’s self-driving division secures $1.2-billion funding from investor group
The autonomous vehicle unit of General Motors (NYSE: GM ) received a big fillip this week after it secured a $1.15-billion…
AB InBev Q1 earnings rise amid solid organic revenue growth
Anheuser-Busch Companies (NYSE: BUD), the manufacturer of popular beer brand Budweiser, Tuesday reported an increase in first-quarter earnings, supported by…
Kraft Heinz to restate financial reports; to delay Q1 results
Pursuant to an investigation into its procurement practices, based on an SEC notification, packaged food company Kraft Heinz (Nasdaq: KHC)…
Earnings: Tyson Foods Q2 profit, sales beat Street view
Packaged food company Tyson Foods (NYSE: TSN) Monday reported better-than-expected earnings and revenues for the second quarter of 2019. The…
Earnings: Newell Brands stock spikes after Q1 results beat estimates
Consumer goods company Newell Brands (Nasdaq: NWL) reported a decline in adjusted earnings for the first quarter of 2019, owing to…
Teva Pharma sinks on Q1 revenue miss amid generic competition; earnings beat
Drugmaker Teva Pharmaceutical (NYSE: TEVA) reported a decline in first-quarter adjusted earnings, owing to a 15% fall in revenues as…